Intraarticular use of tranexamic acid during primary total knee arthroplasty

Authors

  • Prathap Urumkar Surendrakumar Department of Orthopaedics, HOSMAT Hospital, Bengaluru, Karnataka, India https://orcid.org/0000-0001-7680-9189
  • Syed Abdul Hadi Department of Orthopaedics, HOSMAT Hospital, Bengaluru, Karnataka, India
  • Girish Marappa Department of Orthopaedics, HOSMAT Hospital, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20230467

Keywords:

Tranexamic acid, Intraarticular, Total knee arthroplasty

Abstract

Background: Tranexamic acid (TXA) is effective in reduction of blood loss after major surgical procedures. In TKA surgeries, it is commonly administered intravenously. Since there are contraindications of systemic use of TXA, local/intraarticular TXA can also be used. The efficacy of both systemic and local TXA administration is demonstrated in the literature. The aim was to assess the effect of intraarticular TXA during total knee arthroplasty in terms of total blood loss and transfusion rate.

Methods: A total of 50 TKA in 34 patients were included in this prospective study.  Patients received one dose of intraarticular TXA of 3 g after skin closure and before deflation of the tourniquet.

Results: The mean total blood loss in intra-articular TXA was 456.9 ml. None of the patients required transfusion postoperatively including those who underwent bilateral staged TKR. Mean postoperative hemoglobin loss was 1.07.

Conclusions: TXA reduced blood loss and transfusion requirement. Intra-articular administration of TXA seems to be more effective in terms of reducing total blood loss and transfusion rates. We recommend administration of topical TXA in primary TKA in healthy patients to decrease perioperative blood loss.

References

Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systemic review and meta-analysis. J Bone Joint Surg Br. 2011;93(12):1577-85.

Tille E, Mysliwietz J, Beyer F, Postler A, Lützner J. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty. BMC Musculoskelet Disord. 2019;20:341.

Gericke E, DeBeer J, Deacon M, Marais LC. Percutaneous intra-articular tranexamic acid following total knee arthroplasty without drainage to reduce blood loss. SA Orthop J. 2020;19(2).

Marra F, Rosso F, Bruzzoni M, Edeoardo D, Bonasai, Dettoni F. Use of tranexamic acid in total knee arthroplasty. Joint. 2016;4(4):202-13.

Risberg B. The response of the fibrinolytic system in trauma. Acta Chir Scand. 1985;522:245-71.

Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth. 2005;95:33-42.

Harwin SF, Kapadia BH, Issa K, Mont MA. Blood management strategies in total knee arthroplasty. J Knee Surg. 2013;26(6):371-2.

Kalairajah Y, Simpson D, Cossey AJ, Verrall GM, Spriggins AJ. Blood loss after total knee replacement. Effects of computer-assisted surgery. J Bone Joint Surg. 2005;87:1480-2.

Chen JY, Chia S, Lo NN, Yeo SJ. Intra-articular versus intravenous tranexamic acid in primary total knee replacement. Ann Transl Med. 2015;3(3):33.

Digas G, Koutsogiannis I, Meletiadis G, Antonopoulou E, Karamoulas V, Bikos C. Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol. 2015;25(7):1181-8.

Antapur P, Gandhi R, Mahomed NN. Topical and intra-articular tranexamic acid in total knee arthroplasty. Orthogate. 2013.

Gomez-Barrena E, Ortega-Andreu M. Topical intra-articular compared with intravenous tranexamic Acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am. 2014;96:1937-44.

Huang Z, Ma J, Shen B. Combination of intravenous and topical application of tranexamic Acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2014;29:2342-6.

Eriksson, Olaspers S. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Europ J Clin Pharmacol. 1974;7(5):375-80.

Nader SB, Hidalgo JU, Blouch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224-32.

Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004;86(4):561-5.

Levine BR, Haughom BD, Belkin MN. Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2014;29(9):186-8.

Iwai T, Tsuji S, Tomita T. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop. 2013;37:441-5.

Maniar R, Kumar G, Singhi T. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012;470:2605-12.

Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013;21(8):1869-74.

Wang CG, Sun ZH, Liu J, Cao JG, Li ZJ. Safety and efficacy of intra-articular tranexamic acid injection without drainage on blood loss in total knee arthroplasty: A randomized clinical trial. Int J Surg. 2015;20:1-7.

Ishida K, Tsumura N, Kitagawa A. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop. 2011;35(11):1639-45.

Goes RFA, Silva AF, Lyra FS. Prospective randomized study after the use of drains in total knee arthroplasty with implant. Rev Bras Ortop. 2013;48(3):257-62.

Downloads

Published

2023-02-24

Issue

Section

Original Research Articles